Development of Echinocandin Resistance in Candida tropicalis following Short-Term Exposure to Caspofungin for Empiric Therapy

A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

(2018) Anuradha Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Changing epidemiology of candidaemia in Australia

(2017) Belinda Chapman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fruits as the vehicle of drug resistant pathogenic yeasts

(2017) Hsiu-Jung Lo et al.   JOURNAL OF INFECTION

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

(2017) Maiken Cavling Arendrup et al.   JOURNAL OF INFECTIOUS DISEASES

The global problem of antifungal resistance: prevalence, mechanisms, and management

(2017) David S Perlin et al.   LANCET INFECTIOUS DISEASES

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

(2017) Anuradha Chowdhary et al.   PLoS Pathogens

Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait

(2017) Mohammad Asadzadeh et al.   PLoS One

Population structure and molecular genetic characterization of clinical Candida tropicalis isolates from a tertiary-care hospital in Kuwait reveal infections with unique strains

(2017) Khaled Al-Obaid et al.   PLoS One

Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China

(2017) Jin-Yan Wu et al.   Scientific Reports

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2016) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance

(2016) Kelley R. Healey et al.   Nature Communications

Genetic Drivers of Multidrug Resistance in Candida glabrata

(2016) Kelley R. Healey et al.   Frontiers in Microbiology

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study

(2015) R. H. Jensen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

(2015) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study

(2015) B.H. Tan et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clinical perspectives on echinocandin resistance among Candida species

(2015) Ryan K. Shields et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistancein vivoinCandida albicansorchestrated by multiple genetic alterations

(2015) Rasmus Hare Jensen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Echinocandin Failure Case Due to a Previously UnreportedFKS1Mutation in Candida krusei

(2014) Rasmus Hare Jensen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin resistance

(2014) Maiken C. Arendrup et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

(2014) T. Saraya et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

(2013) James S. Lewis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for IdentifyingFKSMutant Candida glabrata Strains and Echinocandin Resistance

(2013) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stepwise Development of a Homozygous S80P Substitution in Fks1p, Conferring Echinocandin Resistance in Candida tropicalis

(2012) Rasmus Hare Jensen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of Human and Soil Candida tropicalis Isolates with Reduced Susceptibility to Fluconazole

(2012) Yun-Liang Yang et al.   PLoS One

Insights into Candida tropicalis nosocomial infections and virulence factors

(2011) M. Negri et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species

(2010) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Invasive Candidiasis in Patients on Micafungin

(2010) C. D. Pfeiffer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media

(2009) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing

(2008) M. Desnos-Ollivier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait

(2008) Mohammad Asadzadeh et al.   MYCOSES